HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
LabMinds Secures Financing to Boost Commercial Growth of The REVO® Robotic System
This funding will help drive the commercialization of its automation system as well as facilitate the expansion of LabMinds’ product portfolio.
Ezra Raises $18M Series A
The AI cancer screening startup will use the funding to expand its suite of medical imaging AIs, and launch the Ezra COVID 360 offering.
Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development
The funds to be used to further the development of an inactivated vaccine against COVID-19 named CoronaVac. The two investors each loaned USD $7.5 million in the form of a convertible loan that bears interest, or, at the investor’s election, converts into 7.5% of the total equity interest of Sinovac R&D.
SOLIUS Announces Investment from Human Longevity Inc. to Support Mission of Improving Health, Performance, and Longevity
SOLIUS technology stimulates the production of vitamin D in the skin using a narrow spectrum of ultraviolet B (UVB) light.
CorVent Medical Closes $4.5M Seed Financing
CorVent Medical notes the financing round is led by the prominent European life sciences venture capital firm Sofinnova Partners with participation from others.
LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures
LaunchPad Medical notes the clinical use of this product is expected to enhance bone healing, reduce infection rates, and improve the cosmetic outcome of these procedures for patients while eliminating the need for metal fixation hardware.
Altoida Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
Altoida reports the FDA-cleared and CE Mark-approved medical device and brain health data platform detects Alzheimer's Disease (AD) up to ten years prior to onset - with up to 94% accuracy.
Mojo Vision Raises Additional $51 Million+ in Series B-1 Round
This new round brings Mojo Vision’s total funding to date to more than $159 million.
AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
AtaCor Medical notes the investment supports efforts to reach US and EU regulatory clearances for AtaCor’s novel extracardiac temporary pacing system as well as development efforts for additional extracardiac therapies.
